Is Roblox Stock a Buy, Sell or Hold?
Gaming company Roblox (NYSE:RBLX) operates a massive platform that allows…
Sell
41
TMDX Quote, Financials, Valuation and Earnings
Last price:
$68.83
Seasonality move
:
18.23%
Day range:
$67.92 - $71.65
52-week range:
$55.00 - $177.37
Dividend yield:
0%
P/E ratio:
68.16x
P/S ratio:
5.49x
P/B ratio:
10.14x
Volume:
776K
Avg. volume:
1.3M
1-year change:
-7.94%
Market cap:
$2.3B
Revenue:
$441.5M
EPS (TTM):
$1.01
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
TMDX
TransMedics Group
|
$109.5M | $0.15 | 27.41% | -31.06% | $102.86 |
|
CUTRQ
Cutera
|
-- | -- | -- | -- | -- |
|
ELMD
Electromed
|
$15.3M | -- | 13.91% | -- | $37.00 |
|
IRIX
IRIDEX
|
$12.8M | -$0.12 | -2.72% | -18.18% | -- |
|
MYO
Myomo
|
$9.9M | -$0.02 | 145.61% | -24% | $9.25 |
|
STXS
Stereotaxis
|
$6.4M | -$0.07 | -0.07% | -20.83% | $4.50 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
TMDX
TransMedics Group
|
$68.84 | $102.86 | $2.3B | 68.16x | $0.00 | 0% | 5.49x |
|
CUTRQ
Cutera
|
$0.02 | -- | $343.2K | -- | $0.00 | 0% | 0.00x |
|
ELMD
Electromed
|
$24.99 | $37.00 | $213.8M | 33.32x | $0.00 | 0% | 3.75x |
|
IRIX
IRIDEX
|
$0.79 | -- | $13.1M | -- | $0.00 | 0% | 0.27x |
|
MYO
Myomo
|
$5.42 | $9.25 | $186.3M | -- | $0.00 | 0% | 6.29x |
|
STXS
Stereotaxis
|
$2.04 | $4.50 | $175.4M | -- | $0.00 | 0% | 6.46x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
TMDX
TransMedics Group
|
69.02% | 2.445 | 24.3% | 7.25x |
|
CUTRQ
Cutera
|
-- | -3.861 | -- | -- |
|
ELMD
Electromed
|
-- | 1.614 | -- | 4.68x |
|
IRIX
IRIDEX
|
51.25% | 1.329 | 9.47% | 0.73x |
|
MYO
Myomo
|
-- | 2.236 | -- | 2.82x |
|
STXS
Stereotaxis
|
-- | 1.401 | -- | 0.74x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
TMDX
TransMedics Group
|
$72M | $8.6M | 5.12% | 19.17% | 8.68% | $6.1M |
|
CUTRQ
Cutera
|
-- | -- | -- | -- | -- | -- |
|
ELMD
Electromed
|
$12.6M | $2.5M | 15.91% | 15.91% | 15.64% | $2.9M |
|
IRIX
IRIDEX
|
$4.3M | -$1.9M | -146.36% | -157.91% | -16.15% | -$3.1M |
|
MYO
Myomo
|
$8.6M | -$245.3K | -48.64% | -48.64% | -2.03% | $2.5M |
|
STXS
Stereotaxis
|
$3.2M | -$7.6M | -139.2% | -139.2% | -120.3% | $1.3M |
TransMedics Group vs. Competitors
-
Which has Higher Returns TMDX or CUTRQ?
Cutera has a net margin of 5.64% compared to TransMedics Group's net margin of --. TransMedics Group's return on equity of 19.17% beat Cutera's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital TMDXTransMedics Group59.21% $0.19 $737.9M CUTRQCutera-- -- -- -
What do Analysts Say About TMDX or CUTRQ?
TransMedics Group has a consensus price target of $102.86, signalling upside risk potential of 49.42%. On the other hand Cutera has an analysts' consensus of -- which suggests that it could grow by 11664.71%. Given that Cutera has higher upside potential than TransMedics Group, analysts believe Cutera is more attractive than TransMedics Group.
Company Buy Ratings Hold Ratings Sell Ratings TMDXTransMedics Group5 3 0 CUTRQCutera0 0 0 -
Is TMDX or CUTRQ More Risky?
TransMedics Group has a beta of 2.121, which suggesting that the stock is 112.09% more volatile than S&P 500. In comparison Cutera has a beta of 1.358, suggesting its more volatile than the S&P 500 by 35.755%.
-
Which is a Better Dividend Stock TMDX or CUTRQ?
TransMedics Group has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Cutera offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. TransMedics Group pays -- of its earnings as a dividend. Cutera pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios TMDX or CUTRQ?
TransMedics Group quarterly revenues are $121.6M, which are larger than Cutera quarterly revenues of --. TransMedics Group's net income of $6.9M is higher than Cutera's net income of --. Notably, TransMedics Group's price-to-earnings ratio is 68.16x while Cutera's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for TransMedics Group is 5.49x versus 0.00x for Cutera. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TMDXTransMedics Group5.49x 68.16x $121.6M $6.9M CUTRQCutera0.00x -- -- --
-
Which has Higher Returns TMDX or ELMD?
Electromed has a net margin of 5.64% compared to TransMedics Group's net margin of 12.11%. TransMedics Group's return on equity of 19.17% beat Electromed's return on equity of 15.91%.
Company Gross Margin Earnings Per Share Invested Capital TMDXTransMedics Group59.21% $0.19 $737.9M ELMDElectromed77.68% $0.22 $43.6M -
What do Analysts Say About TMDX or ELMD?
TransMedics Group has a consensus price target of $102.86, signalling upside risk potential of 49.42%. On the other hand Electromed has an analysts' consensus of $37.00 which suggests that it could grow by 48.06%. Given that TransMedics Group has higher upside potential than Electromed, analysts believe TransMedics Group is more attractive than Electromed.
Company Buy Ratings Hold Ratings Sell Ratings TMDXTransMedics Group5 3 0 ELMDElectromed2 0 0 -
Is TMDX or ELMD More Risky?
TransMedics Group has a beta of 2.121, which suggesting that the stock is 112.09% more volatile than S&P 500. In comparison Electromed has a beta of 0.413, suggesting its less volatile than the S&P 500 by 58.696%.
-
Which is a Better Dividend Stock TMDX or ELMD?
TransMedics Group has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Electromed offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. TransMedics Group pays -- of its earnings as a dividend. Electromed pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios TMDX or ELMD?
TransMedics Group quarterly revenues are $121.6M, which are larger than Electromed quarterly revenues of $16.3M. TransMedics Group's net income of $6.9M is higher than Electromed's net income of $2M. Notably, TransMedics Group's price-to-earnings ratio is 68.16x while Electromed's PE ratio is 33.32x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for TransMedics Group is 5.49x versus 3.75x for Electromed. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TMDXTransMedics Group5.49x 68.16x $121.6M $6.9M ELMDElectromed3.75x 33.32x $16.3M $2M
-
Which has Higher Returns TMDX or IRIX?
IRIDEX has a net margin of 5.64% compared to TransMedics Group's net margin of -16.69%. TransMedics Group's return on equity of 19.17% beat IRIDEX's return on equity of -157.91%.
Company Gross Margin Earnings Per Share Invested Capital TMDXTransMedics Group59.21% $0.19 $737.9M IRIXIRIDEX37.33% -$0.12 $5.4M -
What do Analysts Say About TMDX or IRIX?
TransMedics Group has a consensus price target of $102.86, signalling upside risk potential of 49.42%. On the other hand IRIDEX has an analysts' consensus of -- which suggests that it could grow by 153.13%. Given that IRIDEX has higher upside potential than TransMedics Group, analysts believe IRIDEX is more attractive than TransMedics Group.
Company Buy Ratings Hold Ratings Sell Ratings TMDXTransMedics Group5 3 0 IRIXIRIDEX0 0 0 -
Is TMDX or IRIX More Risky?
TransMedics Group has a beta of 2.121, which suggesting that the stock is 112.09% more volatile than S&P 500. In comparison IRIDEX has a beta of 0.936, suggesting its less volatile than the S&P 500 by 6.383%.
-
Which is a Better Dividend Stock TMDX or IRIX?
TransMedics Group has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. IRIDEX offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. TransMedics Group pays -- of its earnings as a dividend. IRIDEX pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios TMDX or IRIX?
TransMedics Group quarterly revenues are $121.6M, which are larger than IRIDEX quarterly revenues of $11.6M. TransMedics Group's net income of $6.9M is higher than IRIDEX's net income of -$1.9M. Notably, TransMedics Group's price-to-earnings ratio is 68.16x while IRIDEX's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for TransMedics Group is 5.49x versus 0.27x for IRIDEX. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TMDXTransMedics Group5.49x 68.16x $121.6M $6.9M IRIXIRIDEX0.27x -- $11.6M -$1.9M
-
Which has Higher Returns TMDX or MYO?
Myomo has a net margin of 5.64% compared to TransMedics Group's net margin of -2.16%. TransMedics Group's return on equity of 19.17% beat Myomo's return on equity of -48.64%.
Company Gross Margin Earnings Per Share Invested Capital TMDXTransMedics Group59.21% $0.19 $737.9M MYOMyomo71.39% -$0.01 $24.7M -
What do Analysts Say About TMDX or MYO?
TransMedics Group has a consensus price target of $102.86, signalling upside risk potential of 49.42%. On the other hand Myomo has an analysts' consensus of $9.25 which suggests that it could grow by 70.66%. Given that Myomo has higher upside potential than TransMedics Group, analysts believe Myomo is more attractive than TransMedics Group.
Company Buy Ratings Hold Ratings Sell Ratings TMDXTransMedics Group5 3 0 MYOMyomo3 0 0 -
Is TMDX or MYO More Risky?
TransMedics Group has a beta of 2.121, which suggesting that the stock is 112.09% more volatile than S&P 500. In comparison Myomo has a beta of 1.609, suggesting its more volatile than the S&P 500 by 60.902%.
-
Which is a Better Dividend Stock TMDX or MYO?
TransMedics Group has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Myomo offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. TransMedics Group pays -- of its earnings as a dividend. Myomo pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios TMDX or MYO?
TransMedics Group quarterly revenues are $121.6M, which are larger than Myomo quarterly revenues of $12.1M. TransMedics Group's net income of $6.9M is higher than Myomo's net income of -$260.1K. Notably, TransMedics Group's price-to-earnings ratio is 68.16x while Myomo's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for TransMedics Group is 5.49x versus 6.29x for Myomo. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TMDXTransMedics Group5.49x 68.16x $121.6M $6.9M MYOMyomo6.29x -- $12.1M -$260.1K
-
Which has Higher Returns TMDX or STXS?
Stereotaxis has a net margin of 5.64% compared to TransMedics Group's net margin of -118.53%. TransMedics Group's return on equity of 19.17% beat Stereotaxis's return on equity of -139.2%.
Company Gross Margin Earnings Per Share Invested Capital TMDXTransMedics Group59.21% $0.19 $737.9M STXSStereotaxis50.73% -$0.09 $11.4M -
What do Analysts Say About TMDX or STXS?
TransMedics Group has a consensus price target of $102.86, signalling upside risk potential of 49.42%. On the other hand Stereotaxis has an analysts' consensus of $4.50 which suggests that it could grow by 120.59%. Given that Stereotaxis has higher upside potential than TransMedics Group, analysts believe Stereotaxis is more attractive than TransMedics Group.
Company Buy Ratings Hold Ratings Sell Ratings TMDXTransMedics Group5 3 0 STXSStereotaxis2 0 0 -
Is TMDX or STXS More Risky?
TransMedics Group has a beta of 2.121, which suggesting that the stock is 112.09% more volatile than S&P 500. In comparison Stereotaxis has a beta of 1.546, suggesting its more volatile than the S&P 500 by 54.601%.
-
Which is a Better Dividend Stock TMDX or STXS?
TransMedics Group has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Stereotaxis offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. TransMedics Group pays -- of its earnings as a dividend. Stereotaxis pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios TMDX or STXS?
TransMedics Group quarterly revenues are $121.6M, which are larger than Stereotaxis quarterly revenues of $6.3M. TransMedics Group's net income of $6.9M is higher than Stereotaxis's net income of -$7.5M. Notably, TransMedics Group's price-to-earnings ratio is 68.16x while Stereotaxis's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for TransMedics Group is 5.49x versus 6.46x for Stereotaxis. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TMDXTransMedics Group5.49x 68.16x $121.6M $6.9M STXSStereotaxis6.46x -- $6.3M -$7.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Shopify a Millionaire Maker?
Shopify (NYSE:SHOP) is an eCommerce platform, business services provider and…
Is Alphabet Stock No Longer a Good Bet?
Alphabet tripled its price per share over the past 5…
Stock Ideas
Buy
52
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
95
EXOD alert for Mar 21
Exodus Movement [EXOD] is up 17.89% over the past day.
Buy
58
SIG alert for Mar 21
Signet Jewelers [SIG] is down 0.64% over the past day.
Sell
43
HQY alert for Mar 21
HealthEquity [HQY] is up 0.28% over the past day.
